Please Wait

Applying Filters...

Looking for Tox21_300624? Find Controlled & Modified Release used in Tox21_300624 to address drug delivery challenges on PharmaCompass.

Tox21_300624

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 2 USDMF, 1 CEP/COS, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

18 FDF Dossiers, 14 FDA Orange Book, 2 South Africa, 2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 4 DKSH, 2 Nanjing Well Pharmaceutical, 2 Actylis, 6 BASF, 1 Finar, 2 Gangwal Chemicals, 5 Kerry, 2 Microlex e.U, 5 Roquette, 1 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

9 Topical, 8 Thickeners and Stabilizers, 7 Film Formers & Plasticizers, 6 Coating Systems & Additives, 6 Solubilizers, 5 Co-Processed Excipients, 4 Emulsifying Agents, 3 Lubricants & Glidants, 3 Rheology Modifiers, 2 Parenteral, 2 Surfactant & Foaming Agents, 2 Fillers, Diluents & Binders, 1 Controlled & Modified Release, 1 Granulation, 1 Soft Gelatin, 1 Direct Compression

DIGITAL CONTENT

2 NEWS #PharmaBuzz

2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

REF. STANDARDS & IMPURITIES

1 USP, 2 Others

$ Xls

Filters

Tox21_300624

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Actylis

filter Capability Reset all filters

filter Country Reset all filters

01

Actylis

Formnext Forum

Not Confirmed